Health Care & Life Sciences » Pharmaceuticals | Pharmally International Holding Co. Ltd.

Pharmally International Holding Co. Ltd. | Mutual Funds

Mutual Funds that own Pharmally International Holding Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total International Stock Index Fund
564,596
0.72%
0
0%
07/31/2018
Vanguard Emerging Markets Stock Index Fund
528,728
0.68%
0
0.01%
07/31/2018
iShares Core MSCI Emerging Markets ETF
380,704
0.49%
0
0.01%
09/05/2018
DFA Emerging Markets Small Cap Series
285,455
0.37%
9,278
0.05%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
185,543
0.24%
0
0.01%
04/30/2018
Government Pension Fund - Global (The)
162,944
0.21%
89,297
0%
12/31/2017
Vanguard FTSE All World (ex-US) Small Cap
84,932
0.11%
0
0.02%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
46,514
0.06%
0
0.01%
09/05/2018
38,353
0.05%
38,353
5.43%
03/31/2018
Mega Citizen Fund
28,201
0.04%
260
3.25%
03/31/2018

About Pharmally International Holding Co.

View Profile
Address
18th Floor
Taipei TP 11012
Taiwan
Employees -
Website http://www.pharmally.com
Updated 07/08/2019
Pharmally International Holding Co., Ltd. engages in the manufacture and sale of infusion and active pharmaceutical ingredient (API) products. It focuses on basic infusion, infusion therapy, and API. Its products include glucose, sodium chloride, glucose & sodium chloride, compound sodium chloride, lactated ringer's, dextran 40 glucose, dextran 20 glucose, ambroxol hydrochloride & glucose, levofloxacin lactate & sodium chloride injections, nikethamide, dextran powder, and levofloxacin lactate powder.